Celyad Oncology

📍 Mont-Saint-Guibert, Belgium🗓 Founded 2007👥 35 employees💰 Last funded Aug 2020
Biotechnology Research🌐 celyad.com
Website LinkedIn
Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells. Its primary objective is to unlock the potential of its proprietary technology platforms and intellectual property, enabling to be at the forefront of developing next-generation CAR T-cell therapies. By fully leveraging its innovative technology platforms, Celyad Oncology aims to maximize the transformative impact of its candidate CAR T-cell therapies and redefine the future of CAR T-cell treatments. Celyad Oncology is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.
5
Total investors
1
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
3
Belgium
1
Netherlands
1
Investor activity2008–2020 · investors recorded per year
200812013120203
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Celyad Oncology?
Celyad Oncology has 5 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Celyad Oncology last raise funding?
The most recent investment in Celyad Oncology recorded on gritt.io was in August 2020.
When was Celyad Oncology founded?
Celyad Oncology was founded in 2007.
What industry is Celyad Oncology in?
Celyad Oncology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Celyad Oncology based?
Celyad Oncology is headquartered in Mont-Saint-Guibert, Belgium.